(File photo.)

Futures for Canada’s resource-heavy main stock index stretched its four-day winning streak to five on Thursday, even as energy shares tracked weakness in crude prices on slowdown worries fueled by central banks’ “hawkishness”.


Sponsored by
Continuous Good Grades at Serra Alta as Infill Campaign Progresses


Ahead of a key interest rate decision by the European Central Bank, policy tightening exacerbated recession fears across the globe. Fuelled by central banks’ aggressive moves, commodities were weighed down, raising concerns around demand, as oil and metal prices fell on worries about slowdown in production.

Wall Street futures moved higher as electric automaker Tesla topped analysts’ profit target, though futures tracking the Dow struggled for direction during the day before closing in the green.

Today in the Markets

TSX 19,062.85 +42.18 TSX
TSXV 616.25 +9.15 TSXV
CSE 292.38 +7.54 TSXV
DJIA 32,036.90 +162.06 DJIA
NASDAQ 12,059.61 +161.96 NASDAQ
S&P 500 3,998.95 +39.05 S&P 500

The Canadian dollar traded for77.59 cents US compared to 77.64 cents US on Wednesday.

US crude futures traded 3.60 per cent lower at $96.28 a barrel, while the Brent contract lost 2.77 per cent to $103.80 a barrel.

The price of gold was up US$22.87 to US$1,718.87.

In world markets, the Nikkei was up 122.74 to 27,803.00, the Hang Seng was down 315.59 points to 20,574.63, the FTSE was up 6.20 points to 7,270.51, and the DAX was down 35.34 points to 13,246.64.


Get @ the Bell delivered to your email inbox every day!

Sign Up Here





DISCLAIMER: By viewing any material on or distributed by The Market Herald Publishing Ltd. and its Information Providers you agree to both the following disclaimer, and the full disclaimer that can be viewed here.

Any holdings, theories, speculation or trades appearing anywhere on The Market Herald network of websites should not be relied upon for purposes of transacting securities or other investments, nor should they be construed as an offer or solicitation of an offer to sell or buy any security. This applies to any material regardless of source, placement, presentation or reproduction. Any Information Providers to The Market Herald or employees of The Market Herald may from time to time have positions in the stocks or other entities mentioned anywhere on The Market Herald Network of websites. You bear responsibility for your own investment research and decisions and should seek the advice of a qualified securities professional before making any investment. The Market Herald and its contributors makes no guarantee as to the validity of any information, speculation, theories or research presented herein whether pertaining to the past, present or future. The Service and The Materials are provided by The Market Herald and other Information Providers on an “as is” basis, and The Market Herald and other Information Providers expressly disclaim any and all warranties, express or implied, including, without limitation, warranties of satisfactory quality and fitness for a particular purpose, with respect to the service or any materials and products. In no event shall The Market Herald and other Information Providers be liable for any direct, indirect, incidental, punitive, or consequential damages of any kind whatsoever with respect to The Service, The Materials, and The Products.


More From The Market Online
Doctor with a bladder replica

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient’s Guide

As a patient with BCG-Unresponsive NMIBC CIS, bladder removal is far from the only option on the table in 2024.
Nervous system

NervGen Pharma: Proof that NVG-291 works?

Tantalizing anecdotal “evidence” has just been published suggesting that NervGen’s prospective wonder-drug, NVG-291, is delivering the goods.
Santa looking at stock charts

@ the Bell: TSX and S&P 500 ascend into the weekend

Canada’s TSX index added almost 200 points on Friday thanks to gains across industries, including a 23.13 per cent gain from BlackBerry.